---
figid: PMC10969160__cancers-16-01083-g001
figtitle: Summary of potential therapeutic targets
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10969160
filename: PMC10969160__cancers-16-01083-g001.jpg
figlink: /pmc/articles/PMC10969160/figure/F1
number: F1
caption: 'The summary of potential therapeutic targets. Abbreviations: ALDH, aldehyde
  dehydrogenase; AMPK, 5′AMP-activated protein kinase; BMI-1, B-lymphoma Mo-MLV insertion
  region 1; CD44, cluster of differentiation 44; EGF, epidermal growth factor; GLI,
  transcription factor GLI; GRP48, G Protein Coupled Receptor 48; GSK3β, glycogen
  synthase kinase-3β; HER2, human epidermal growth factor receptor 2; Hh, hedgehog
  signalling pathway; Hoxa5, homeobox A5; IL-1,-6, interleukin-1,-6; LRP5/6, Low-density
  lipoprotein receptor-related protein 5; MMP-7, Matrix Metalloprotease-7; mTOR, mammalian
  target of rapamycin; MYC, MYC MYC transcription factor; NF-κB, nuclear factor κB;
  PD-1, programmed death receptor-1; PD-L1, programmed death receptor-1 ligand; PI3K,
  phosphatidylinositol 3-kinases; PTCH1, receptor called Patched 1; SMO, signal transducer
  called Smoothened; SMYD3, SET and MYND domain containing 3; SUFU, cytoplasmic protein;
  TCF1, T cell factor 1; TNF-α, tumour necrosis factor α; TNFR, tumour necrosis factor
  receptor; Wnt, Wnt signalling pathway'
papertitle: Characteristics of Cancer Stem Cells and Their Potential Role in Endometrial
  Cancer
reftext: Karolina Frąszczak, et al. Cancers (Basel). 2024 Mar;16(6).
year: '2024'
doi: 10.3390/cancers16061083
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: cancer stem cells | endometrial cancer | CD133 | CD117 | CD44
automl_pathway: 0.956872
figid_alias: PMC10969160__F1
figtype: Figure
redirect_from: /figures/PMC10969160__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10969160__cancers-16-01083-g001.html
  '@type': Dataset
  description: 'The summary of potential therapeutic targets. Abbreviations: ALDH,
    aldehyde dehydrogenase; AMPK, 5′AMP-activated protein kinase; BMI-1, B-lymphoma
    Mo-MLV insertion region 1; CD44, cluster of differentiation 44; EGF, epidermal
    growth factor; GLI, transcription factor GLI; GRP48, G Protein Coupled Receptor
    48; GSK3β, glycogen synthase kinase-3β; HER2, human epidermal growth factor receptor
    2; Hh, hedgehog signalling pathway; Hoxa5, homeobox A5; IL-1,-6, interleukin-1,-6;
    LRP5/6, Low-density lipoprotein receptor-related protein 5; MMP-7, Matrix Metalloprotease-7;
    mTOR, mammalian target of rapamycin; MYC, MYC MYC transcription factor; NF-κB,
    nuclear factor κB; PD-1, programmed death receptor-1; PD-L1, programmed death
    receptor-1 ligand; PI3K, phosphatidylinositol 3-kinases; PTCH1, receptor called
    Patched 1; SMO, signal transducer called Smoothened; SMYD3, SET and MYND domain
    containing 3; SUFU, cytoplasmic protein; TCF1, T cell factor 1; TNF-α, tumour
    necrosis factor α; TNFR, tumour necrosis factor receptor; Wnt, Wnt signalling
    pathway'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LRP5
  - LRP6
  - CTNNB1
  - MIR1246
  - MIR9-2
  - MIR544A
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - GSK3A
  - GSK3B
  - TNFRSF1A
  - TNF
  - IL1B
  - IL6
  - NFKB1
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - EGF
  - ERBB2
  - SMO
  - SMOX
  - MYC
  - SNAI1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - ALDH1A1
  - ALDH1A2
  - ALDH1A3
  - ALDH2
  - ALDH3A1
  - ALDH3A2
  - ALDH3B1
  - ALDH5A1
  - ALDH7A1
  - ALDH9A1
  - BMI1
  - COMMD3-BMI1
  - POU5F1
  - POU5F1P3
  - POU5F1P4
  - SOX2
  - NANOG
  - CD44
  - HNF1A
  - TCF7
  - MMP7
  - HOXA5
  - SMYD3
  - SUFU
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - ITK
  - SLC22A3
  - tyrosine
  - TNF-a
  - inhibitors
  - EGF
  - inhibitor
---
